Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercaptosuccinic acid)

Clinical Toxicology

Volumn 45, Issue 4, 2007, Pages 424-428

  Stenehjem, Aud E ^a   Vahter, Marie ^b   Nermell, Barbro ^b   Aasen, Jorulf ^a   Lierhagen, Syverin ^c   Mørland, Jørg ^d   Jacobsen, Dag ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Arsenic poisoning; Chelating therapy; DMSA; Neuropathy

Indexed keywords

ARSENIC; SUCCIMER;

ADULT; ARSENIC POISONING; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CHELATION THERAPY; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DIARRHEA; DISEASE SEVERITY; FEMALE; HAIR ANALYSIS; HOSPITALIZATION; HUMAN; METABOLIC CLEARANCE RATE; MULTIPLE ORGAN FAILURE; NAUSEA; PERIPHERAL NEUROPATHY; QUADRIPLEGIA; URINALYSIS; VOMITING; WEAKNESS;

EID: 34248196516     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701232489     Document Type: Article

References (42)

1. Winship KA. Toxicity of inorganic arsenic salts. Adverse Drug React Acute Poisoning Rev 1984; 3(3):129-160.
2. Zelent A. Hot on the TRAIL of acute promyelocytic leukemia. Nat Med 2001; 7(6):662-4.
3. WHO. Arsenic and arsenic compounds. 2nd ed. Environmental Health Criteria 224, WHO. Geneva: World Health Organization, 2001:521.
4. Hughes MF. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 2002; 133:1-16.
5. Hindmarsch JT, McCurdy RF. Clinical and environmental aspects of arsenic toxicity. Crit Rev Clin Lab Sci 1986; 16(1):45-56.
6. Hall AH. Chronic arsenic poisoning. Toxicol Lett 2002; 128(1-3):69-72.
7. Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J 2003; 79:391-396.
8. IARC. Some drinking-water desinfectants and contamintants, including arsenic. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: International Agency for Research on Cancer, 2004, vol. 84.
9. NRC. Arsenic in drinking water: 2001 update. Washington D.C.: National Academy Press, 2001.
10. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002; 181-182:211-217.
11. Hirano S, Kobayashi Y, Cui X, Hayakawa T, Shraim A. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol Appl Pharmacol 2004; 198:458-467.
12. Schwerdtle T, Walter I, Hartwig A. Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. DNA Repair (Amst) 2003; 2:1449-1463.
13. Guha Mazumder DN. Chapter 4: Diagnosis and treatment of chronic arsenic poisoning. Revised Draft, 2000; 4.3.1: 21-26. (Accessed December 12, 2005, at http://www.who.int/water_sanitation_health/dwq/arsenicun4.pdf.)
14. Heyman A, Pfeiffer JB, Willett RW, Taylor HM. Peripheral neuropathy caused by arsenical intoxication. N Engl J Med 1956; 254:401-9.
15. Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure - a review of the literature and a risk estimate. Scand J Work Environ Health 1998; 24:1-51.
16. Vahter M. What are the chemical forms of arsenic in urine, and what can they tell us about exposure? Clin Chem 1994; 40(5):1-2.
17. Vahter M, Concha G, Nermell B, Nilsson R, Dulout F, Natarajan N. A unique metabolism of inorganic arsenic in native Andean women. Eur J Pharmacol Environ Toxicol Pharmacol 1995; 293:455-462.
18. Vahter M, Lind B. Concentrations of arsenic in urine of the general population in Sweden. Sci Tot Environ 1986; 54:1-12.
19. Andrén P, Schütz A, Vahter M, Attewell R, Johansson L, Willers S, Skerfving S. Environmental exposure to lead and arsenic among children living near a glassworks. Sci Total Environ 1988; 77:25-34.
20. Jensen GE, Christensen JM, Poulsen OM. Occupational and environmental exposure to arsenic - increased urinary arsenic level in children. Sci Total Environ 1991; 107:169-177.
21. Buchet JP, Staessen J, Roels H, Lauwerys R, Fagard R. Geographical and temporal differences in the urinary excretion of inorganic arsenic: a Belgian population study. Occup Environ Med 1996; 53:320-327.
22. Trepka MJ, Heinrich J, Schulz C, Krause C, Popescu M, Wjst M, Wichmann HE. Arsenic burden among children in industrial areas of eastern Germany. Sci Total Environ 1996; 180:95-105.
23. Kristiansen J, Molin Christensen J, Iversen BS, Sabbioni E. Toxic trace element reference levels in blood and urine: influence of gender and life-style factors. Sci Total Environ 1997; 204:147-160.
24. Kavanagh P, Farago ME, Thornton I, Goessler W, Kuehnelt D, Schlagenhaufen C, Irgolic C. Urinary arsenic species in Devon and Cornwall residents, UK. A pilot study. Analyst 1998; 123(1):27-29.
25. Mahieu P, Buchet JP, Roels HA, Lauwerys R. The metabolism of arsenic in humans acutely intoxicated by As2O3. Its significance for the duration of BAL therapy. Clin Toxicol 1981; 18:1067-1075.
26. Foà V, Colombi A, Maroni M, Buratti M, Calzaferri G. The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic. Sci Total Environ 1984; 34:241-259.
27. Quatrehomme G, Ricq O, Lapalus P, Jacomet Y, Ollier A. Acute arsenic intoxication: Forensic and toxicologic aspects (an observation). J Forensic Sci 1992; 37:1163-1171.
28. Lovell MA, Farmer JG. Arsenic speciation in urine from humans intoxicated by inorganic arsenic compounds. Human Toxicol 1985; 4:203-214.
29. Heinrich-Ramm R, Schaller H, Horn J, Angerer J. Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning. Arch Toxicol 2003; 77:63-68.
30. Gong Z, Jiang G, Cullen WR, Aposhian HV, Le XC. Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate. Chem Res Toxicol 2002; 15:1318-1323.
31. Schwerdtle T, Walter I, Hartwig A. Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. DNA Repair (Amst) 2003; 9:1449-63.
32. Hopps HC. The biological bases for using hair and nail for analyses of trace elements. Sci Total Environ 1997; 7:71-89.
33. Hostynek JJ, Hinz RS, Lorence CR, Price M, Guy RH. Metals and the skin. Critical Rev Toxicol 1993; 23:171-235.
34. Vienna A, Capucci E, Wolfsperger M, Hauser G. Heavy metals in hair of students in Rome. Anthrop Anz 1995; 53:27-32.
35. Raie RM. Regional variation in As, Cu, Hg, and Se and interaction between them. Ecotoxicol Environ Safety 1996; 35:248-252.
36. Paulsen F, Mai S, Zellmer U, Alsen-Hinrichs C. Blood and hair arsenic, lead and cadmium analysis of adults and correlation analysis with special reference to eating habits and other behavioral influences. Gesundheitswesen 1996; 58:459-464.
37. Rogers CE, Tomita AV, Trowbridge PR, Gone JK, Chen J, Zeeb P, Hemond HF, Thilly WG, Olmez I, Durant JL. Hair arsenic analysis does not support hypothesized arsenic and chromium exposure from drinking water in Woburn, Massachusetts. Environ Health Perspect 1997; 105(10):1090-1097.
38. Kurttio P, Komulainen H, Hakala E, Kahelin H, Pekkanen J. Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch Environ Contam Toxicol 1998; 34(3):297-305.
39. Poklis A, Saady JJ. Arsenic poisoning: acute or chronic? Suicide or murder? Am J Forensic Med Pathol 1990; 11:226-232.
40. Koons RD, Peters CA. Axial distribution of arsenic in individual human hairs by solid sampling graphite furnace AAS. J Anal Toxicol 1994; 18:36-40.
41. Tripathi N, Flora SJ. Effects of some thiol chelators on enzymatic activities in blood, liver and kidneys of acute arsenic (III) exposed mice. Biomed Environ Sci 1998; 11(1):38-45.
42. Guha Mazumder DN, De BK, Santra A, Ghosh N, Das S, Lahiri S, Das T. Randomized placebo-controlled trial of 2.3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water. J Toxicol Clin Toxicol 2001; 39(7):665-74.